Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

In 2021, polyester-based polyurethane (PE-PUR) foam used in Philips Respironics ventilators, CPAP and BiPAP machines was found to degrade and cause serious health issues or death, leading to a mass ...

ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...

Medical device maker Phillips formally entered into a consent decree that stops the company from selling sleep apnea machines in the United States over health concerns that include cancer. The decree ...